Skip navigation

Cambridge MBE Joins MAP BioPharma in New Role

17 July 2017

17 July 2017, Cambridge UK: MAP BioPharma is delighted to announce that it has appointed Harriet Fear MBE to a new role in the company as its Chief Consulting Officer. 

The family run organisation has experienced rapid and sustained growth in the last five years and is now at the stage where there is such demand for its services that it is expanding its highly motivated and professional team with this new role. 

Christian Hill, Chief Executive of MAP BioPharma explains: ‘We are thrilled by how our MAP on-line market access service has grown, and with that our tailored and bespoke consultancy services for our members. It is a pivotal and exciting time for MAP BioPharma and we want to further nurture the creative talents we already have within the team, and bring in exceptional leadership qualities to add to our management team and Board’. 

He goes on to explain ‘Harriet is the perfect fit for us, with her international focus, strong belief in making a positive difference and understanding the needs and interests of our members. Having run the largest membership organisation for the Life Science and Healthcare sector in Europe while Chief Executive of One Nucleus, she is very well placed to support our future. We are hugely excited by the appointment’. 

Harriet commented: ‘MAP BioPharma’s offer and values are exceptional. The company has a clear and fantastic offer for the sector. In these difficult times, the importance of demonstration of value, timely and professional advice and hands-on support are critical. I especially appreciate that the whole team is deeply committed to its current and future members. 

She continues ‘Having been Chief Executive of One Nucleus for over 8 years, it was time for me to seek new challenges and I would only move from what I once described as the best job in the world, to a role which will bring me fresh and exciting challenges and opportunities to support our innovative sector. I have found this with MAP BioPharma and look forward with great anticipation and excitement to being a key part of the company’s future and its support for its members’.

Harriet will formally assume her role on 18 September 2017.


About MAP BioPharma
MAP was founded in 2012 with a vision to become the market leader in accelerating patient access to medicines, devices and diagnostics.

To achieve this, MAP provides services that help BioPharma and MedTech clients achieve optimal pricing and market access. We have developed online resources for the UK & Ireland, France, Germany, Italy and Spain and we plan to extend development to include other EU countries. Outside Europe, Canada is now available and plans are in place to add Japan, Brazil, Turkey, Australia & New Zealand. MAP’s consultancy services supplement MAP online by providing expert product specific, one to one expert strategic advice on a consulting basis throughout the product lifecycle across the EU.

We have helped over 70 clients with over 100 product licensing, pricing and HTA submissions with unique expertise in highly-specialised orphan drugs.

Harriet’s background and biography:

Harriet was appointed a Member of the Order of the British Empire (MBE) in the Queen’s Birthday 2016 Honours List. The award is in recognition of Harriet’s services to the ‘healthcare and life sciences’ sector. Upon the award, her Chair, Jon Green commented ‘It is a testament to her hard work and influence across the sector in the UK and across the globe’.

Harriet joined One Nucleus as Chief Executive in February 2009. She previously worked as a Diplomat with the British Foreign Office for 21 years serving in over 17 countries around the globe. Half her career was spent in the commercial field, latterly heading UK Trade & Investments’ national life sciences trade team for over 5 years. During her varied Foreign Office career, she was Deputy Ambassador three times, Private Secretary to the Minister for Europe, led an evacuation of Brits out of the Congo and worked in Khymer Rouge territory with Scotland Yard on a hostage crisis.

She was attracted to the role at One Nucleus because she wanted to spend time helping companies maximise their competitiveness. Since her arrival at One Nucleus, she and her excellent team have redefined its membership (now life science and healthcare, not only biotech), formed strong and strategic relations with like-minded counterparts around the globe for the benefit of members and merged the former organisation (known as ERBI) with the London Biotechnology Network to enhance the offer to members and create a stronger critical mass on the international stage. 

Harriet was appointed as the Prime Minister’s Business Ambassador for Life Sciences in January 2014. She continues in this role which sees her leading international delegations, speaking at major sector events, briefing visiting VIP’s and dignitaries from around the world and advising the Department of International Trade (DIT) on its strategy.

For further information please contact:
Simone Borley
MAP BioPharma Limited
Contact details: or 01480 832360